Materialise NV, founded in 1990 and headquartered in Leuven, Belgium, is a pioneer in 3D printing solutions, offering a wide range of software and services that enable companies across industries to innovate and optimize their additive manufacturing processes. With over 30 years of experience, Materialise has developed a robust portfolio that includes medical applications, industrial production, and consumer goods, emphasizing customization, efficiency, and sustainability. The company's solutions support sectors such as healthcare, automotive, aerospace, and art and design, providing tools that facilitate the transition from traditional manufacturing to digital production. Materialise operates globally, collaborating with clients to transform ideas into tangible outcomes through the power of 3D printing.
The 3D-printed bioresorbable splint is set to help children with airway conditions, with an FDA trial enrolling 35 children to assess its safety for wider use.
The fully integrated Materialise Mimics platform works for enhanced efficiencies in advanced 3D planning and personalized device creation, & provide accessible patient care for medical device companies & hospitals globally.